ClinicalTrials.Veeva

Menu

Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding

A

Assiut University

Status

Enrolling

Conditions

Prediction of Variceal Bleeding

Study type

Observational

Funder types

Other

Identifiers

NCT06614114
Alb/bl in variceal bleeding

Details and patient eligibility

About

Albumin bilirubin index as a predictor of outcome of variceal bleeding

Full description

This study is to clarify the predictive value of albumin bilirubin index for recurrent bleeding within 3 month after endoscopic treatment in patients with cirrhosis and EGVB

Enrollment

48 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age between 18-80 years old

Exclusion criteria

  • Hcc Hematological disease

Trial contacts and locations

1

Loading...

Central trial contact

Heba Sayed Zaki; Ahmed M.Ashmawy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems